Structured intermittent interruption of chronic HIV infection treatment with highly active antiretroviral therapy: effects on leptin and TNF-alpha.

AIDS Research and Human Retroviruses
M Montes de Oca ArjonaJ A Girón-González

Abstract

The changes in nutritional parameters and adipocytokines after structured intermittent interruption of highly active antiretroviral treatment of patients with chronic HIV infection are analyzed. Twenty-seven patients with chronic HIV infection (median CD4+ T cell count/microl: nadir, 394; at the beginning of structured interruptions, 1041; HIV viral load: nadir, 41,521 copies/ml; at the beginning of structured interruptions <50 copies/ml; median time of previous treatment: 60 months) were evaluated during three cycles of intermittent interruptions of therapy (8 weeks on/4 weeks off). CD4+ T cell count, HIV viral load, anthropometric measures, and serum concentrations of triglycerides, cholesterol, leptin, and tumor necrosis factor and its soluble receptors I and II were determined. After the three cycles of intermittent interruptions of therapy, no significant differences in CD4+ T cell count/microl, viral load, or serum concentrations of cholesterol or triglycerides with reference to baseline values were found. A near-significant higher fatty mass (skinfold thicknesses, at the end, 121 mm, at the beginning, 100 mm, p = 0.100), combined with a significant increase of concentration of leptin (1.5 vs. 4.7 ng/ml, p = 0,044), as we...Continue Reading

References

May 1, 1992·Immunology Today·L A Tartaglia, D V Goeddel
Jan 1, 1995·European Journal of Haematology·A Diez-RuizD Fuchs
Feb 1, 1996·The New England Journal of Medicine·R V ConsidineT L Bauer
Jun 17, 1999·AIDS·P R HarriganJ S Montaner
May 5, 2000·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·S P Reidy, J Weber
Oct 12, 2000·Nature·E S RosenbergB D Walker
Jan 11, 2001·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J A Girón-GonzálezC Fernández-Gutiérrez
Dec 26, 2001·JAMA : the Journal of the American Medical Association·F Lori, J Lisziewicz
Feb 22, 2002·The New England Journal of Medicine·Elif Arioglu OralAbhimanyu Garg
Apr 30, 2002·Current Opinion in Infectious Diseases·V Miller
Jul 4, 2002·JAMA : the Journal of the American Medical Association·Patrick G YeniPaul A Volberding
Oct 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Ume L Abbas, John W Mellors
Oct 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Annette OxeniusRodney E Phillips
Nov 20, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Morris SchambelanUNKNOWN International AIDS Society-USA
Jan 25, 2003·AIDS·Marek FischerUNKNOWN Swiss HIV Cohort Study
Mar 11, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G Sonia NagyChristos S Mantzoros
Mar 26, 2003·Journal of Cardiovascular Pharmacology and Therapeutics·Sanjiv SharmaTetsuo Ishimori
Apr 26, 2003·Journal of Pediatric Endocrinology & Metabolism : JPEM·A LiottaL Titone
May 28, 2003·Archives of Internal Medicine·Catherine FagardUNKNOWN Swiss HIV Cohort Study
Oct 3, 2003·AIDS·Jintanat AnanworanichUNKNOWN Swiss HIV Cohort Study
Nov 14, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Patrick M TarwaterJoel E Gallant

❮ Previous
Next ❯

Citations

Nov 8, 2008·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Giota TouloumiUNKNOWN CASCADE Collaboration
Jan 15, 2008·Current Opinion in Infectious Diseases·Nicholas I Paton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.